Chronic Obstructive Pulmonary Disease Patients' Acceptance in E-Health Clinical Trials.
Saeed Mardy AlghamdiAhmed M Al RajahYousef S AldabayanAbdulelah M AldhahirJaber Saud AlqahtaniAbdulaziz A AlzahraniPublished in: International journal of environmental research and public health (2021)
Current TH COPD interventions have a pooled acceptance rate of 51%, but this is accompanied by a high dropout rate of 63%. Acceptance and dropout levels in TH clinical trials can be affected by sociodemographic and intervention-related factors. This knowledge enlightens designs for well-accepted future TH clinical trials. PROSPERO registration number CRD4201707854.
Keyphrases
- clinical trial
- chronic obstructive pulmonary disease
- healthcare
- end stage renal disease
- chronic kidney disease
- ejection fraction
- phase iii
- phase ii
- randomized controlled trial
- public health
- newly diagnosed
- prognostic factors
- mental health
- physical activity
- open label
- patient reported outcomes
- double blind
- patient reported